Zobrazeno 1 - 6 of 6 pro vyhledávání: '"Terhi, Tallgren"'
2
Three two-site apoA-I immunoassays using phage expressed detector antibodies - Preliminary clinical evaluation with cardiac patients
Autor: Priyanka, Negi, Taina, Heikkilä, Terhi, Tallgren, Päivi, Malmi, Juha, Lund, Juha, Sinisalo, Jari, Metso, Matti, Jauhiainen, Kim, Pettersson, Urpo, Lamminmäki, Janita, Lövgren
Publikováno v: Journal of pharmaceutical and biomedical analysis. 194
High density lipoproteins (HDL) are a heterogenous group of subpopulations differing in protein/lipid composition and in their anti-atherogenic function. There is a lack of specific and robust assays which can target the functionality of HDL with res
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::9d0bfe4db0c512d2226d872a93be5f8a
https://pubmed.ncbi.nlm.nih.gov/33309125
Zobrazit plný text záznamu
3
Large-Scale Purification of Photon-Upconversion Nanoparticles by Gel Electrophoresis for Analogue and Digital Bioassays
Autor: A. Król, Antonín Hlaváček, Hans H. Gorris, Matthias Jürgen Mickert, Naděžda Pizúrová, Terhi Tallgren, Satu Lahtinen, Tero Soukka
Publikováno v: Analytical chemistry. 91(2)
The performance of photon-upconversion nanoparticles (UCNPs) as background-free luminescent labels in bioanalytical applications strongly depends on the preparation of well-defined and water-dispersible nanoconjugates. We have exploited the separatio
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8254bc4f4861c6424a764f5f3c8adbf3
https://pubmed.ncbi.nlm.nih.gov/30525484
Zobrazit plný text záznamu
4
Validation of Novel Biomarkers for Prostate Cancer Progression by the Combination of Bioinformatics, Clinical and Functional Studies
Autor: Jesse Mattsson, Matthias Nees, Natalia Tong Ochoa, Riina Minna Väänänen, Terhi Tallgren, Peter J. Boström, Anders Bjartell, Pekka Taimen, Saeid Alinezhad, Kim Pettersson, Malin Åkerfelt, Yifeng Li
Publikováno v: PLoS ONE, Vol 11, Iss 5, p e0155901 (2016)
PLoS ONE
The identification and validation of biomarkers for clinical applications remains an important issue for improving diagnostics and therapy in many diseases, including prostate cancer. Gene expression profiles are routinely applied to identify diagnos
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27f221120cae865b6962c0c530616481
http://europepmc.org/articles/PMC4873225?pdf=render
Zobrazit plný text záznamu
6
Stratification of aggressive prostate cancer from indolent disease—Prospective controlled trial utilizing expression of 11 genes in apparently benign tissue
Autor: Esa Kähkönen, Terhi Tallgren, Saeid Alinezhad, Peter J. Boström, Otto Ettala, Kari T. Syvänen, Markku Kallajoki, Pekka Taimen, Ileana Montoya Perez, Kim Pettersson, Hannu J. Aronen, Riina-Minna Väänänen, Matthias Nees, Ivan Jambor
Publikováno v: Urologic Oncology: Seminars and Original Investigations. 34:255.e15-255.e22
Background: The aim of the study was to evaluate the diagnostic power of molecular markers in men with a clinical suspicion of prostate cancer (PCa) using apparently benign areas as targeted by magnetic resonance imaging (MRI). Methods: In the study,
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::799d7973653a3d180ba4e846ffcb75cb
https://doi.org/10.1016/j.urolonc.2015.12.014
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje